| Name | Title | Contact Details |
|---|
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
Careguide Systems is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Squip is a Lebanon, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Madame Vanier Children's Services is a London, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Established in 1973, the National Health Foundation (NHF) is an innovative leader in seeking ways to improve the healthcare delivery system. One of the Foundation's first initiatives was the development of a bioengineering program for hospitals. This